Trials / Completed
CompletedNCT02502682
Chlorhexidine Bathing Effect on Clostridium Difficile Rates
Effect of Daily Chlorhexidine Bathing on Clostridium Difficile Rates on the General Medical Floor in Patients Receiving Antibiotics
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 167 (actual)
- Sponsor
- Jared Brooks · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clostridium difficile (C. diff.) infections, whether nosocomial or community borne, may present with profound diarrhea, especially in those patients receiving antibiotics. Based on a preliminary review of hospital data, the investigators have found that these symptomatic c. diff infections occur with a relatively high incidence at Delnor Hospital. Notwithstanding their high mortality, one recent study attributes a near quadrupling of hospitalization costs to c. diff infections. Chlorhexidine baths have been shown in multiple randomized trials to help reduce the incidence of highly virulent pathogens and hospital acquired infections. Further, several studies show a favorable effect of reducing the incidence of c. diff infections by using Chlorhexidine baths on ICU patients. Far fewer studies, however, have focused on the effects of these baths on general medical/surgical wards. This investigation seeks to study the effect of the daily use of 2% Chlorhexidine gluconate wipes in patients on the general medical/surgical wards who are exposed to antibiotics for a suspected or confirmed infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sage 2% Chlorhexidine Gluconate Cloth Patient Preoperative Skin Preparation | Daily bathing. |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2015-07-20
- Last updated
- 2016-07-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02502682. Inclusion in this directory is not an endorsement.